Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

20.46
+1.176.07%
Post-market: 20.500.0400+0.20%19:49 EST
Volume:4.06M
Turnover:82.01M
Market Cap:2.59B
PE:-33.07
High:20.72
Open:19.39
Low:19.27
Close:19.29
52wk High:20.72
52wk Low:6.78
Shares:126.55M
Float Shares:112.38M
Volume Ratio:1.44
T/O Rate:3.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6186
EPS(LYR):-1.5162
ROE:-10.12%
ROA:-8.42%
PB:3.30
PE(LYR):-13.49

Loading ...

10x Genomics Is Maintained at Hold by TD Cowen

Dow Jones
·
Jan 08

CareDx Partners with 10x Genomics to Launch ImmuneScape Multiomics Platform

Reuters
·
Jan 07

10x Genomics to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 30, 2025

10x Genomics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Dec 22, 2025

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
Dec 16, 2025

10x Genomics : Barclays Raises Target Price to $22 From $17

THOMSON REUTERS
·
Dec 15, 2025

10x Genomics Cut to Neutral From Buy by Citigroup

Dow Jones
·
Dec 12, 2025

Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18

MT Newswires Live
·
Dec 11, 2025

10x Genomics Inc : Citigroup Cuts to Neutral From Buy

THOMSON REUTERS
·
Dec 11, 2025

U.S. RESEARCH ROUNDUP-BioNTtech, GE Vernova, Synopsys

Reuters
·
Dec 11, 2025

10x Genomics (TXG): Assessing Valuation After a 36% One-Month Share Price Rebound

Simply Wall St.
·
Dec 05, 2025

10x Genomics Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Dec 02, 2025

Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17

MT Newswires Live
·
Dec 02, 2025

10x Genomics (TXG) Is Up 19.8% After Pan-Cancer Atlas Collaboration With Garvan and University of Tokyo

Simply Wall St.
·
Nov 27, 2025

Will 10x Genomics' (TXG) Role in ASTRA Shift Its Competitive Edge in Precision Oncology?

Simply Wall St.
·
Nov 20, 2025

10x Genomics Joins Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas

Reuters
·
Nov 18, 2025

10x Genomics Appoints Randy Wu as General Counsel Replacing Eric Whitaker

Reuters
·
Nov 14, 2025

10x Genomics to Join Wolfe Research Healthcare Conference

Reuters
·
Nov 12, 2025

10x Genomics Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Nov 12, 2025

10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation

Simply Wall St.
·
Nov 08, 2025